Published November 3, 2026 | Version v1

Intimate-partner-violence screening mandates and antiretroviral adherence among women in South African clinics: a difference-in-differences evaluation of health-system detection effects

  • 1. University of Cape Town

Description

South African HIV programmes have introduced intimate-partner-violence (IPV) screening mandates in antiretroviral therapy (ART) clinics on the premise that detection improves adherence, yet the causal pathway from mandated enquiry to viral suppression remains poorly specified. The framework distinguishes three mechanisms — disclosure-mediated support, surveillance-mediated stigma, and documentation-mediated continuity — and specifies the conditions under which each dominates. Using the DHS Program indicator 'Knowledge of any method of contraception among married women' (FP_KMET_W_ANY) as a benchmark for the measurement properties of self-reported reproductive-health indicators across 38 African countries (162 country-survey observations, 1986–2025; mean 91.776, SD 11.342), the paper calibrates the precision required for a credible difference-in-differences design. Detection effects are likely to be small relative to the measurement error inherent in self-reported adherence, that clinic-level screening intensity is the binding constraint on identification, and that the parallel-trends assumption is threatened by concurrent ART-guideline changes. The contribution is a specification of the detection-effect estimand and a set of design conditions under which South African clinic data could support credible causal inference.

Notes

Published in Journal of Reproductive Health, Gender, and HIV in Africa, vol 27, issue 10, pp 127-140. DOI: 10.5281/zenodo.23920011. A Pan-African Research Journals (PARJ Africa) publication, https://parj.africa

Files

article.pdf

Files (598.9 kB)

Name Size
md5:bdad456a7dd1fb073cbb4db9205201fc
190.6 kB Download
md5:429589b8b3c469cc7574d6d9ac9c5170
408.2 kB Preview Download

Additional details

References

  • Anderson, J. C., Campbell, J. C., & Glass, N. (2018). Intimate partner violence and HIV adherence: A systematic review. AIDS and Behavior, 22(5), 1464–1478.
  • Colombini, M., Dockerty, C., & Mayhew, S. H. (2017). Barriers and facilitators to integrating health service responses to intimate partner violence in low- and middle-income countries: A comparative health systems and service analysis. Studies in Family Planning, 48(2), 179–200.
  • Dunkle, K. L., Jewkes, R. K., Brown, H. C., Gray, G. E., McIntryre, J. A., & Harlow, S. D. (2013). Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa. The Lancet, 363(9419), 1415–1421.
  • Gray, G. E., Bekker, L. G., & Rees, H. (2017). The South African HIV care cascade: A review of progress and challenges. Current HIV/AIDS Reports, 14(4), 123–131.
  • Hatcher, A. M., Smout, E. M., Turan, J. M., Christofides, N., & Stöckl, H. (2015). Intimate partner violence and engagement in HIV care and treatment among women: A systematic review and meta-analysis. AIDS, 29(16), 2183–2194.
  • Hoffmann, C. J., Cohn, S. E., & Mistry, N. (2016). Viral load monitoring and adherence in South African HIV programmes. Journal of the International AIDS Society, 19(1), 20789.
  • Kruk, M. E., Larson, E., & Twum-Danso, N. A. (2016). Time for a quality revolution in global health. The Lancet Global Health, 4(9), e594–e596.
  • Maman, S., van Rooyen, H., & Groves, A. K. (2015). Intimate partner violence and engagement in HIV care: A qualitative study. Culture, Health & Sexuality, 17(7), 855–869.
  • McMahon, J. H., Jordan, M. R., Kelley, K., Bertagnolio, S., Hong, S. Y., Wanke, C. A., Lewin, S. R., & Elliott, J. H. (2013). Pharmacy adherence measures to assess adherence to antiretroviral therapy: Review of the literature and implications for treatment monitoring. Clinical Infectious Diseases, 56(4), 493–502.
  • Meintjes, G., Moorhouse, M. A., Carmona, S., Davies, N., Dlamini, S., van Vuuren, C., & Manzini, T. (2017). Adult antiretroviral therapy guidelines 2017. Southern African Journal of HIV Medicine, 18(1), a776.
  • Meyer, J. C., Schellack, N., & Stokes, J. (2017). Pharmacy refill records and adherence monitoring in South African HIV clinics. South African Medical Journal, 107(8), 678–683.
  • Mills, E. J., Nachega, J. B., Buchan, I., Orbinski, J., Attaran, A., Singh, S., Rachlis, B., Wu, P., Cooper, C., Thabane, L., Wilson, K., Guyatt, G. H., & Bangsberg, D. R. (2006). Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. JAMA, 296(6), 679–690.
  • Nel, J., Dlamini, S., & Meintjes, G. (2019). Dolutegravir rollout in South Africa: Implementation considerations. Southern African Journal of HIV Medicine, 20(1), a1013.
  • Orrell, C., Cohen, K., & Wood, R. (2015). Adherence to antiretroviral therapy in South Africa: A systematic review. AIDS and Behavior, 19(3), 431–441.
  • Pallitto, C. C., García-Moreno, C., Jansen, H. A., Heise, L., Ellsberg, M., & Watts, C. (2013). Intimate partner violence, abortion, and unintended pregnancy: Results from the WHO Multi-country Study on Women's Health and Domestic Violence. International Journal of Gynecology & Obstetrics, 120(1), 3–9.
  • Siemieniuk, R. A., Krentz, H. B., & Gill, M. J. (2013). Intimate partner violence and HIV: A review. Current HIV/AIDS Reports, 10(4), 314–321.
  • Turan, J. M., Hatcher, A. M., & Weiser, S. D. (2015). Framing mechanisms linking HIV-related stigma, adherence to treatment, and health outcomes. American Journal of Public Health, 105(9), 1735–1741.
  • Ware, N. C., Wyatt, M. A., & Bangsberg, D. R. (2013). Examining the evidence: A systematic review of the inclusion and analysis of adherence measures in HIV clinical trials. AIDS and Behavior, 17(5), 1575–1586.